Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.
1. In the retinal inner nuclear layer of the majority of species, a dopaminergic neuronal network has been visualized in either amacrine cells or the so-called interplexiform cells. 2. Binding studies of retinal dopamine receptors have revealed the existence of both D1- as well D2-subtypes. The D1-subtype was characterized by labeled SCH 23390 (Kd ranging from 0.175 to 1.6 nM and Bmax from 16 to 482 fmol/mg protein) and the D2-subtype by labelled spiroperidol (Kd ranging from 0.087 to 1.35 nM and Bmax from 12 to 1500 fmol/mg protein) and more selectively by iodosulpiride (Kd 0.6 nM and Bmax 82 fmol/mg protein) or methylspiperone (Kd 0.14 nM and Bmax 223 fmol/mg protein). 3. Retinal dopamine receptors have been also shown to be positively coupled with adenylate cyclase activity in most species, arguing for the existence of D1-subtype, whereas in some others (lower vertebrates and rats), a negative coupling (D2-subtype) has been also detected in peculiar pharmacological conditions implying various combinations of dopamine or a D2-agonist with a D1-antagonist or a D2-antagonist in the absence or presence of forskolin. 4. A subpopulation of autoreceptors of D2-subtype (probably not coupled to adenylate cyclase) also seems to be involved in the modulation of retinal dopamine synthesis and/or release. 5. Light/darkness conditions can affect the sensitivity of retinal dopamine D1 and/or D2-receptors, as studied in binding or pharmacological experiments (cAMP levels, dopamine synthesis, metabolism and release). 6. Visual function(s) of retinal dopamine receptors were connected with the regulation of electrical activity and communication (through gap junctions) between horizontal cells mediated by D1 and D2 receptor stimulation. Movements of photoreceptor cells and migration of melanin granules in retinal pigment epithelial cells as well as synthesis of melatonin in photoreceptors were on the other hand mediated by the stimulation of D2-receptors. 7. Other physiological functions of dopamine D1-receptors respectively in rabbit and in embryonic avian retina would imply the modulation of acetylcholine release and the inhibition of neuronal growth cones.
Schorderet
M
M
Department of Pharmacology, University Medical Center, Geneva, Switzerland.
Nowak
J Z
JZ
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001191:Arylamine N-Acetyltransferase / Q000037:antagonists & inhibitors; D001552:Benzazepines / Q000378:metabolism; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D004873:Ergolines / Q000494:pharmacology; D008027:Light; D019257:Quinpirole; D011954:Receptors, Dopamine / Q000145:classification* / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D012160:Retina / Q000378:metabolism*; D015290:Second Messenger Systems; D013045:Species Specificity; D013134:Spiperone / Q000031:analogs & derivatives / Q000378:metabolism; D013469:Sulpiride / Q000031:analogs & derivatives / Q000378:metabolism; D014714:Vertebrates / Q000502:physiology
D001552:Benzazepines; D004873:Ergolines; D011954:Receptors, Dopamine; C045105:iodosulpride; D005576:Colforsin; D019257:Quinpirole; D013134:Spiperone; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D013469:Sulpiride; C039167:3-N-methylspiperone; D000242:Cyclic AMP; D001191:Arylamine N-Acetyltransferase; D000262:Adenylyl Cyclases; D004298:Dopamine